Trevi Therapeutics, Inc. (33)
Browse by Contract Category
Contracts
-
Second Amendment to Loan and Security Agreement, dated August 13, 2021, by and between Silicon Valley Bank and the Registrant
(Filed With SEC on November 10, 2021)
-
Offer Letter, dated June 17, 2021, by and between the Registrant and Lisa Delfini
(Filed With SEC on August 12, 2021)
-
First Amendment to Exclusive License Agreement, dated June 24, 2021, by and between Rutgers, The State University of New Jersey and the Registrant
(Filed With SEC on August 12, 2021)
-
Non-Employee Director Compensation Policy
(Filed With SEC on March 25, 2021)
-
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers
(Filed With SEC on April 5, 2019)
-
First Amendment to Lease, dated December 5, 2017, by and between the Registrant and 195 Church Street Associates, LLC
(Filed With SEC on April 5, 2019)
-
Form of 3.5-Year Warrant
(Filed With SEC on October 19, 2021)
-
Form of 7-Year Warrant
(Filed With SEC on October 19, 2021)
-
Form of 3.5-Year Common Stock Warrant
(Filed With SEC on October 1, 2021)
-
Form of 7-Year Common Stock Warrant
(Filed With SEC on October 1, 2021)
-
Form of Pre-Funded Warrant
(Filed With SEC on October 1, 2021)
-
Loan and Security Agreement, dated as of August 13, 2020, between Silicon Valley Bank and Trevi Therapeutics, Inc
(Filed With SEC on November 12, 2020)
-
Offer Letter, dated December 4, 2012, by and between the Registrant and Thomas R. Sciascia
(Filed With SEC on March 16, 2020)
-
Description of Registrants Securities
(Filed With SEC on March 16, 2020)
-
Trevi Therapeutics, Inc. Executive Separation Benefits and Retention Plan
(Filed With SEC on September 24, 2019)
-
Share Purchase Agreement, dated as of May 6, 2019, by and between the Registrant and New Enterprise Associates 16, L.P
(Filed With SEC on May 7, 2019)
-
Exclusive License Agreement, dated as of May 13, 2011, by and between the Registrant and Penwest Pharmaceuticals Co
(Filed With SEC on April 22, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on April 22, 2019)
-
2019 Employee Stock Purchase Plan
(Filed With SEC on April 5, 2019)
-
Specimen Stock Certificate evidencing the shares of common stock
(Filed With SEC on April 5, 2019)
-
Second Amended and Restated Investors Rights Agreement dated as of July 14, 2017
(Filed With SEC on April 5, 2019)
-
2012 Stock Incentive Plan, as amended
(Filed With SEC on April 5, 2019)
-
Form of Nonstatutory Stock Option Agreement under the 2012 Stock Incentive Plan
(Filed With SEC on April 5, 2019)
-
2019 Stock Incentive Plan
(Filed With SEC on April 5, 2019)
-
Form of Stock Option Agreement under the 2019 Stock Incentive Plan
(Filed With SEC on April 5, 2019)
-
Non-Employee Director Compensation Policy
(Filed With SEC on April 5, 2019)
-
Employment Agreement, dated December 4, 2012, by and between the Registrant and Jennifer L. Good
(Filed With SEC on April 5, 2019)
-
Offer Letter, dated April 23, 2018, by and between the Registrant and Christopher J. Seiter
(Filed With SEC on April 5, 2019)
-
Offer Letter, dated August 29, 2018, by and between the Registrant and Yann Mazabraud
(Filed With SEC on April 5, 2019)
-
Indefinite Term Employment Contract, dated August 29, 2018, by and between the Registrant and Yann Mazabraud
(Filed With SEC on April 5, 2019)
-
Exclusive License Agreement between the Registrant and Rutgers, the State University of New Jersey, effective November 6, 2018
(Filed With SEC on April 5, 2019)
-
Exclusive License Agreement, dated as of May 13, 2011, by and between the Registrant and Penwest Pharmaceuticals Co
(Filed With SEC on April 5, 2019)
-
Indenture of Lease, dated February 6, 2013, by and between First Niagara Bank, N.A. and the Registrant
(Filed With SEC on April 5, 2019)
